BioAge Labs, Inc. (BIOA) stock
BIOANasdaqPharmaceutical PreparationsFiscal year ends December 31
$5.10−0.12 (-2.30%)
Close on Nov 17, 2026Market cap $234.07MP/E –Yield –
BioAge Labs total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
BioAge Labs's total debt was $0 at Jun 30, 2026. For fiscal 2025 it was $2.65M, down 68.9% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.65M | -68.9% |
| FY2024 | Dec 31, 2024 | $8.50M | -40.1% |
| FY2023 | Dec 31, 2023 | $14.20M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $0 | -100.0% |
| Q1 FY2026 | Mar 31, 2026 | $1.16M | -83.6% |
| Q4 FY2025 | Dec 31, 2025 | $2.65M | -68.9% |
| Q3 FY2025 | Sep 30, 2025 | $4.13M | -58.5% |
| Q2 FY2025 | Jun 30, 2025 | $5.60M | -60.6% |
| Q1 FY2025 | Mar 31, 2025 | $7.06M | – |
| Q4 FY2024 | Dec 31, 2024 | $8.50M | – |
| Q3 FY2024 | Sep 30, 2024 | $9.94M | – |
| Q4 FY2023 | Dec 31, 2023 | $14.20M | – |
See a number that looks wrong?